Kang Tae Hyun, Seong Baik Lin
Biopharmaceutical Chemistry Major, School of Applied Chemistry, Kookmin University, Seoul, South Korea.
Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Front Microbiol. 2020 Sep 25;11:1927. doi: 10.3389/fmicb.2020.01927. eCollection 2020.
Solubility of recombinant proteins (i.e., the extent of soluble versus insoluble expression in heterogeneous hosts) is the first checkpoint criterion for determining recombinant protein quality. However, even soluble proteins often fail to represent functional activity because of the involvement of non-functional, misfolded, soluble aggregates, which compromise recombinant protein quality. Therefore, screening of solubility and folding competence is crucial for improving the quality of recombinant proteins, especially for therapeutic applications. The issue is often highlighted especially in bacterial recombinant hosts, since bacterial cytoplasm does not provide an optimal environment for the folding of target proteins of mammalian origin. Antibody fragments, such as single-chain variable fragment (scFv), single-chain antibody (scAb), and fragment antigen binding (Fab), have been utilized for numerous applications such as diagnostics, research reagents, or therapeutics. Antibody fragments can be efficiently expressed in microorganisms so that they offer several advantages for diagnostic applications such as low cost and high yield. However, scFv and scAb fragments have generally lower stability to thermal stress than full-length antibodies, necessitating a judicious combination of designer antibodies, and bacterial hosts harnessed with robust chaperone function. In this review, we discuss efforts on not only the production of antibodies or antibody fragments in microorganisms but also scFv stabilization via (i) directed evolution of variants with increased stability using display systems, (ii) stabilization of the interface between variable regions of heavy (V ) and light (V ) chains through the introduction of a non-native covalent bond between the two chains, (iii) rational engineering of V -V pair, based on the structure, and (iv) computational approaches. We also review recent advances in stability design, increase in avidity by multimerization, and maintaining the functional competence of chimeric proteins prompted by various types of chaperones.
重组蛋白的溶解度(即在异源宿主中可溶性表达与不溶性表达的程度)是确定重组蛋白质量的首要检查标准。然而,即使是可溶性蛋白也常常由于非功能性、错误折叠的可溶性聚集体的存在而无法表现出功能活性,这些聚集体会影响重组蛋白的质量。因此,筛选溶解度和折叠能力对于提高重组蛋白的质量至关重要,特别是对于治疗应用而言。这个问题在细菌重组宿主中尤为突出,因为细菌细胞质不能为哺乳动物来源的靶蛋白折叠提供最佳环境。抗体片段,如单链可变片段(scFv)、单链抗体(scAb)和抗原结合片段(Fab),已被用于众多应用,如诊断、研究试剂或治疗。抗体片段可以在微生物中高效表达,因此它们在诊断应用中具有低成本和高产率等诸多优势。然而,scFv和scAb片段通常比全长抗体对热应激的稳定性更低,这就需要明智地组合设计抗体以及具有强大伴侣功能的细菌宿主。在这篇综述中,我们不仅讨论了在微生物中生产抗体或抗体片段的努力,还讨论了通过以下方法实现scFv稳定化:(i)使用展示系统对稳定性增加的变体进行定向进化;(ii)通过在重链(V )和轻链(V )可变区之间引入非天然共价键来稳定两者之间的界面;(iii)基于结构对V -V 对进行理性工程设计;(iv)计算方法。我们还综述了稳定性设计的最新进展、通过多聚化提高亲和力以及各种类型的伴侣蛋白促使嵌合蛋白保持功能活性方面的进展。